Effectiveness and safety of Sofosbuvir/Velpatasvir/Voxilaprevir for retreatment of chronic hepatitis C patients with a previous failure to direct-acting antivirals: a real-life study from the Navigatore Lombardia and Veneto Networks. (February 2019) - Degasperi, E.; Spinetti, A.; Lombardi, A.; Landonio, S.; Scotton, P.; Pasulo, L.; Carlotto, A.; Giorgini, A.; Pozzoni, P.; Angeli, P.; Carrara, M.; Puoti, M.; et al.